Differential effect of the autoimmune yaa and ipr genes on the acceleration of lupus‐like syndrome in mrl/mpj mice

The Yaa gene (Y chromosome‐linked autoimmune acceleration), linked to the BXSB/MpJ Y chromosome, and the autosomal recessive Ipr (lymphoproliferation) gene have been shown to accelerate the progression of the lupus‐like autoimmune syndrome in the BXSB and MRL strains, respectively. To compare more directly the role of the Yaa and Ipr genes in the development of the autoimmune syndrome, the Ychromosome of BXSB mice was transferred to MRL mice by backcross procedures, and the effect of the Yaa gene on the autoantibody formation and the development of lupus‐like nephritis in MRL mice was investigated in comparison with those bearing the Ipr mutation. The Yaa gene as well as the Ipr gene were able to shorten the life span of MRL mice as a result of the accelerated development of lethal lupus‐like nephritis. However, the acceleration promoted by the Yaa gene (50% mortality rate: 12 months) was less severe than that induced by the Ipr gene (50% mortality rate: 7 months). This may be related to the finding that the Ipr gene enhanced the production of a large spectrum of autoantibodies, including anti‐DNA, rheumatoid factors and anti‐gp70, and of cryoglobulins, whereas only anti‐gp70 production among the autoantibodies studied was markedly enhanced by the Yaa gene. The selective autoimmune accelerating effect of the Yaa gene was similarly observed in (NZW x MRL)F1 hybrid mice. Our results suggest that the Yaa gene, unlike the Ipr gene, exhibits selective autoimmune accelerating activity, but as as result of increased formation of certain nephritogenic autoantibodies such as anti‐gp70 antibodies, the Yaa gene is able to accelerate the progression of lupus‐like nephritis in lupus‐prone mice.

[1]  F. Spertini,et al.  IgG3 is the major source of cryoglobulins in mice. , 1989, Journal of immunology.

[2]  S. Izui,et al.  The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus‐like syndrome in (NZW × C57BL/6)F1 male mice, but not in C57BL/6 male mice , 1988, European journal of immunology.

[3]  S. Schurmans,et al.  Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies. , 1987, Journal of immunology.

[4]  F. Spertini,et al.  Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. , 1987, Journal of immunology.

[5]  R. DePinho,et al.  Tailor-made monoclonal antibodies. , 1986, Annals of internal medicine.

[6]  A. Steinberg,et al.  Studies of consomic mice bearing the Y chromosome of the BXSB mouse. , 1985, Journal of immunology.

[7]  V. Kelley,et al.  Induction of various autoantibodies by mutant gene lpr in several strains of mice. , 1984, Journal of immunology.

[8]  S. Izui,et al.  Acute SLE in F1 hybrids between SB/Le and NZW mice; prominently enhanced formation of gp70 immune complexes by a Y chromosome-associated factor from SB/Le mice. , 1984, Journal of immunology.

[9]  Y. Sasaki,et al.  Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease. , 1983, Journal of immunology.

[10]  D. Pisetsky,et al.  Ipr gene control of the anti-DNA antibody response. , 1982, Journal of immunology.

[11]  S. Izui,et al.  Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis , 1981, The Journal of experimental medicine.

[12]  S. Izui,et al.  (NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction , 1981, The Journal of experimental medicine.

[13]  J. Roths,et al.  A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. , 1979, Arthritis and rheumatism.

[14]  A. Theofilopoulos,et al.  Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus , 1979, The Journal of experimental medicine.

[15]  A. Theofilopoulos,et al.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.

[16]  K. Keck Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinant , 1975, Nature.

[17]  R. Stroud,et al.  Rabbit C1q: purification, functional and structural studies. , 1972, Journal of immunological methods.

[18]  E. Engvall,et al.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. , 1972, Journal of immunology.

[19]  P. Stastny,et al.  Cold-insoluble complexes and complement levels in systemic lupus erythematosus. , 1969, The New England journal of medicine.

[20]  L. Hanauer,et al.  Studies of cryoproteins in systemic lupus erythematosus. , 1967, The Journal of clinical investigation.

[21]  S. Izui,et al.  Enzyme-linked immunosorbent assay for detection of retroviral gp70 and gp70-anti-gp70 immune complexes in sera from SLE mice. , 1988, Clinical and experimental immunology.

[22]  H. Wigzell,et al.  New horizons in animal models for autoimmune disease , 1987 .